The Effect of Quercetin on Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Beclin1, P62, and LC3: An Experimental Study
Authors:
- Ioannis KatsarosIoannis Katsaros
- Maria SotiropoulouMSMaria Sotiropoulou
- Michail VailasMVMichail Vailas
- Fotini PapachristouFPFotini Papachristou
- Paraskevi PapakyriakopoulouPPParaskevi Papakyriakopoulou
- Marirena GrigoriouMGMarirena Grigoriou
- Nikolaos KostomitsopoulosNikolaos Kostomitsopoulos
- Alexandra GiatromanolakiAGAlexandra Giatromanolaki
- Georgia ValsamiGVGeorgia Valsami
- Alexandra TsarouchaATAlexandra Tsaroucha
- Dimitrios SchizasDimitrios Schizas
Open Access
- 11 December 2024
- Vol. 16 (24) , 4282
Abstract
Background/Objectives: Non-alcoholic fatty liver disease (NAFLD) is a major metabolic disorder with no established pharmacotherapy. Quercetin, a polyphenolic flavonoid, demonstrates potential hepatoprotective effects but has limited bioavailability. This study evaluates the impact of quercetin on NAFLD and assesses the roles of autophagy-related proteins in disease progression. Methods: Forty-seven male C57BL/6J mice were fed a high-fat diet (HFD) for 12 weeks to induce NAFLD, followed by quercetin treatment for 4 weeks. Mice were divided into baseline, control, and two quercetin groups, receiving low (10 mg/kg) and high (50 mg/kg) doses. Liver histology was scored using the NAFLD Activity Score (NAS). Immunohistochemistry and immunoblotting were performed to analyze autophagy markers. Results: Quercetin-treated groups showed significant reductions in NAS compared to controls (p = 0.011), mainly in steatosis and steatohepatitis. Immunohistochemistry indicated increased expression of autophagy markers LCA and p62 in quercetin groups. Western blot analysis revealed significant elevations in LC3A in the treated groups, suggesting improved autophagic activity and lipid degradation. Conclusions: Quercetin effectively reduces NAFLD severity and modulates autophagy-related proteins. These findings suggest that quercetin enhances autophagic flux, supporting its therapeutic potential for NAFLD. Additional research is needed to clarify the molecular mechanisms of quercetin and to determine the optimal dosing for clinical application.Keywords
This publication has 64 references indexed in Scilit:
- Tetrahydrocurcumin ameliorates hepatic steatosis by restoring hepatocytes lipophagy through mTORC1-TFEB pathway in nonalcoholic steatohepatitisBiomedicine & Pharmacotherapy, 2024
- Polyphenols improve non‐alcoholic fatty liver disease via gut microbiota: A comprehensive reviewFood Science & Nutrition, 2024
- Expression of LC3A, LC3B and p62/SQSTM1 autophagy proteins in hepatocellular carcinoma (HCC) tissues and the predicted microRNAs involved in the autophagy-related pathwayJournal of Molecular Histology, 2024
- Baicalin attenuated metabolic dysfunction‐associated fatty liver disease by suppressing oxidative stress and inflammation via the p62–Keap1–Nrf2 signalling pathway in db/db micePhytotherapy Research, 2023
- Targeting the lysosome: Mechanisms and treatments for nonalcoholic fatty liver diseaseJournal of Cellular Biochemistry, 2022
- Exploring the oxidation and iron binding profile of a cyclodextrin encapsulated quercetin complex unveiled a controlled complex dissociation through a chemical stimulusBiochimica et Biophysica Acta (BBA) - General Subjects, 2018
- Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animalsAtherosclerosis, 2018
- Lipotoxicity induces hepatic protein inclusions through TANK binding kinase 1–mediated p62/sequestosome 1 phosphorylationHepatology, 2017
- Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in miceHepatology, 2016
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005